SynthesisBMC cancer2021

Prophylactic pegfilgrastim to prevent febrile neutropenia among patients receiving biweekly (Q2W) chemotherapy regimens: a systematic review of efficacy, effectiveness and safety.

Reshma Mahtani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.